reviewTop 1% cited

Adherence to antiretroviral therapy during and after pregnancy in low-income, middle-income, and high-income countries

AIDS · 2012 · Vol. 26(16) · pp. 2039–2052

Jean B. Nachega✉(GTx (United States))Olalekan A. Uthman(Stellenbosch University)Jean Anderson(Johns Hopkins Hospital)Karl Peltzer(University of the Free State)Sarah WampoldMark F. Cotton(National Centre for Infectious Diseases)Edward J. Mills(University of Ottawa)Yuh‐Shan Ho✉(Asia University)Jeffrey S. A. Stringer(University of Alabama at Birmingham)James McIntyre(Anova Health Institute)Lynne Mofenson

View via DOI Publisher page

Abstract

Our findings indicate that only 73.5% of pregnant women achieved optimal ART adherence. Reaching adequate ART adherence levels was a challenge in pregnancy, but especially during the postpartum period. Further research to investigate specific barriers and interventions to address them is urgently needed globally.

HIV/AIDS Research and Interventions Adolescent Sexual and Reproductive Health HIV, Drug Use, Sexual RiskMedicinePregnancyConfidence intervalMEDLINEAntiretroviral therapyPillYoung adultObstetricsDemographyHuman immunodeficiency virus (HIV)

MeSH terms

Assessment of Medication AdherenceAdultDeveloping CountriesFemaleHIV SeropositivityHumansMalePregnancyPregnancy Complications, InfectiousSocial ClassUnited StatesDrug MonitoringInfectious Disease Transmission, VerticalDeveloped CountriesAnti-HIV Agents

Citations

479

FWCI

18.45

field-weighted impact

References

120

Percentile

100%

vs. same field & year

Citations per year

Cited by